Tolerability and efficacy of the trifunctional antibody removab^®(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/I... by Bois A du, Moiseenko V, Biakhov M, Eiermann W, Ströhlein M, Makhson A, Lichinitser M, Pfisterer J, Schmalfeldt B, Sommer H, Gorbounova V, Burges A, Wimberger P, Kimmig R